Jim Breyer’s Bloomberg Interview from Davos

Breyer Capital founder and CEO Jim Breyer speaks with Lisa Abramowicz at the World Economic Forum’s annual meeting in Davos, Switzerland. (Source: Bloomberg)

Watch Interview >
Broad Institute cofounder Schreiber leaves to launch new research institution Arena BioWorks

Called Arena BioWorks, the new organization has been in the works for several years. For Schreiber, the seeds were planted in early 2020. He and Thomas Cahill, cofounder and managing director of the investment firm Newpath Partners, had formed a 12-person group called Scientists to Stop COVID-19.

When Schreiber moved on from the pandemic-era project, he took that lesson with him. He had in mind to set up an organization not unlike the Broad Institute, but with a key difference. It would be funded wholly by private financiers—from the research stage to company formation and potential commercialization.

Others quickly came on board. Stephen Pagliuca, a healthcare investor and co-owner of the Boston Celtics who’d previously backed the Pagliuca Life Lab at Harvard University, became “intimately involved” with the planning process, Schreiber says. Pagliuca helped orchestrate a meeting in December 2021 with Jim Breyer, founder and CEO of Breyer Capital and an early backer of Facebook, and Michael Dell, the founder of Dell Technologies. Both executives agreed to support the project within 25 min.

Read Full Story >
Jim Breyer joins ‘Squawk Box’ from WEF

Breyer Capital founder and CEO Jim Breyer joins ‘Squawk Box’ to discuss the impact of AI on the VC landscape, how AI can change health care, and more.

Watch Interview >
Breyer Capital’s Healthcare AI Investment Thesis: Learnings and Predictions (Fall 2023 Update):

Since our last Healthcare AI investment thesis update, we’ve experienced a continuing and profound transformation at the intersection of healthcare, life sciences, and artificial intelligence (AI). At Breyer Capital, we’ve been investing in companies and teams operating at this intersection since 2016. This past spring, our work helped catalyze the inaugural University of Texas-Breyer Capital-UTIMCO Healthcare Summit, a two-day event in Austin, Texas featuring perspectives from medical experts, top AI researchers, and healthcare and life sciences executives…

Read Full Post >
Nvidia looks unstoppable over next three years, says Breyer Capital’s Jim Breyer
CNBC, May 24, 2023
Jim Breyer, Breyer Capital founder and CEO, joins ‘Squawk on the Street’ to discuss Breyer’s call on Nvidia back at Davos, Alphabet’s proprietary chip sets and the chief executive’s thoughts on Meta.
Watch Interview >